Pakistani Population under Dark Shadows Of Diabetes: Do we need a Different Protocol for Diagnosing Type-2 Diabetes Mellitus?
DOI:
https://doi.org/10.51253/pafmj.v75iSUPPL-7.12781Keywords:
Diagnostic cut-off, Hyperglycemia, Pakistani population, Type 2 diabetes mellitus (T2DM)Abstract
Type-2 diabetes mellitus(T2DM) is taking on a mammoth toll in subcontinental population. Current international guidelines to screen T2DM requires although inclusive of majority of T2DM cases, still remain exclusive of many cases especially in Asian population. WHO data suggests Pakistan to be third in terms of diabetes cases and predicted to lead the world by next decade and half. Our country needs holistic, dedicated and evidence-based country-specific approach to manage this incoming sweetening menace of our times. Recent researches including Diabetes Prevalence Survey of Pakistan(DPS-PAK) and Pakistan Recommendation for optimal management of Diabetes from Primary to Tertiary Care Level(PROMPT) studies identifies an immediate need for timely focus for the Pakistani population. A wholesome multi-prong strategy for T2DM is needed. Our study group planned to review diabetes screening for our locale. While the obesity patterns and BMI have already been acknowledged as “different”, we believe diagnostic screening age for T2DM to be varied for sub-continental population. We reviewed local and regional to trace down our normality definition for screening hyperglycemia. Any sensitive “medically defined stipulation for normality limit” for screening age mandates a well-researched evidence base with benefits likely to mitigate disease. Our reviewed data consistently highlighted an emerging trend among youth and adolescence for developing hyperglycemia among the Asians communities at an early age especially so in Pakistani population. Therefore, we suggested a very robust and early age (1-8 years with high incorporating high anthropometric indices) for screening T2DM for Pakistani population followed by periodic monitoring.
Downloads
References
Adnan M, Aasim M. Prevalence of Type 2 Diabetes Mellitus in Adult Population of Pakistan: A Meta-Analysis of Prospective Cross-Sectional Surveys. Ann Glob Health 2020; 86(1): 7.
https://doi.org/10.5334/aogh.2679
2. Khan SH. Asian Obesity Paradox: Implications for Healthcare Management Approaches. J Coll Physicians Surg Pak 2021; 31(7): 757-758. https://doi.org/10.29271/jcpsp.2021.07.757
3. International Diabetic Federation: Pakistan. [Internet]. Available at: https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/pakistan/ [Accessed on August 9, 2024]
4. Siddique K. Evaluation of knowledge of type 2 diabetes among university students in Punjab, Pakistan. Rev Educ Admin Law 2021; 4(3): 675-688.
5. Shera AS, Basit A, Team P. Pakistan's Recommendations for Optimal Management of diabetes from Primary to Tertiary care level (PROMPT). Pak J Med Sci 2017; 33(5): 1279-1283.
https://doi.org/10.12669/pjms.335.13665
6. Aamir AH, Ul-Haq Z, Mahar SA, Qureshi FM, Ahmad I, Jawa A, Sheikh A, et al. Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open 2019; 9(2): e025300.
https://doi.org/10.1136/bmjopen-2018-025300
7. Basit A, Fawwad A, Abdul Basit K, Waris N, Tahir B, Siddiqui IA; NDSP members. Glycated hemoglobin (HbA1c) as diagnostic criteria for diabetes: the optimal cut-off points values for the Pakistani population; a study from second National Diabetes Survey of Pakistan (NDSP) 2016-2017. BMJ Open Diabetes Res Care 2020; 8(1): e001058.
https://doi.org/10.1136/bmjdrc-2019-001058
8. Basit A, Askari S, Zafar J, Riaz M, Fawwad A; NDSP Members. NDSP 06: Prevalence and risk factors for obesity in urban and rural areas of Pakistan: A study from second National Diabetes Survey of Pakistan (NDSP), 2016-2017. Obes Res Clin Pract 2021; 15(1): 19-25. https://doi.org/10.1016/j.orcp.2020.11.007
9. Chowdhury MAB, Islam M, Rahman J, Uddin MT, Haque MR, Uddin MJ et al. Changes in prevalence and risk factors of hypertension among adults in Bangladesh: An analysis of two waves of nationally representative surveys. PLoS One 2021; 16(12): e0259507. https://doi.org/10.1371/journal.pone.0259507
10. Islam SM, Lechner A, Ferrari U, Laxy M, Seissler J, Brown J, et al. Healthcare use and expenditure for diabetes in Bangladesh. BMJ Global Health 2017; 2(1): e000033.
https://doi.org/10.1136/bmjgh-2016-000033
11. Maiti S, Akhtar S, Upadhyay AK. Socioeconomic inequality in awareness, treatment and control of diabetes among adults in India: Evidence from National Family Health Survey of India (NFHS), 2019–2021. Sci Rep 2023; 13: 2971.
https://doi.org/10.1038/s41598-023-29978-y
12. Cao Q, Zheng R, He R, Wang T, Xu M, Lu J, et al. Use of the new guidelines on an earlier age threshold of 35 years for diabetes screening can identify an additional 6.3 million undiagnosed individuals with diabetes and 72.3 million individuals with prediabetes among Chinese adults: An analysis of a nationally representative survey. Metabolism 2022; 134: 155238.
https://doi.org/10.1016/j.metabol.2022.155238
13. Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia 2023; 66(6): 986-1002. Epub 2023 Mar 10. Erratum in: Diabetologia. 2023; 66(6): 1165.
https://doi.org/10.1007/s00125-023-05913-8
14. Peer N, Balakrishna Y, Durao S. Screening for type 2 diabetes mellitus. Cochrane Database Syst Rev 2020; 5(5): CD005266.
https://doi.org/10.1002/14651858.CD005266.pub2
15. Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia 2021; 64(2): 275-287.
https://doi.org/10.1007/s00125-020-05319-w
16. Jonas DE, Vander Schaaf EB, Riley S, Allison BA, Middleton JC, Baker C, et al. Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2022; 328(10): 968-979. https://doi.org/10.1001/jama.2022.7957
17. Strati M, Moustaki M, Psaltopoulou T, Vryonidou A, Paschou SA. Early onsettype 2 diabetes mellitus: an update. Endocrine 2024; 85(3): 965-978.
https://doi.org/10.1007/s12020-024-03772-w
18. Zeitler P, Galindo RJ, Davies MJ, Bergman BK, Thieu VT, Nicolay C, et al. Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A PostHoc Analysis from the SURPASS Clinical Trial Program. Diabetes Care 2024; 47(6): 1056-1064.
https://doi.org/10.2337/dc23-2356
19. Akhtar S, Nasir JA, Ali A, Asghar M, Majeed R, Sarwar A et al. Prevalence of type-2 diabetes and prediabetes in Malaysia: A systematic review and meta-analysis. PLoS One 2022; 17(1): e0263139. https://doi.org/10.1371/journal.pone.0263139
20. Haghravan S, Mohammadi-Nasrabadi F, Rafraf M. A critical review of national diabetes prevention and control programs in 12 countries in Middle East. Diabetes Metab Syndr 2021; 15(1): 439-445. https://doi.org/10.1016/j.dsx.2021.02.002
21. Lee KA, Kim DJ, Han K, Chon S, Moon MK; Committee of Clinical Practice Guideline of Korean Diabetes Association. Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022. Diabetes Metab J 2022; 46(6): 819-826.
https://doi.org/10.4093/dmj.2022.0364
22. Cando LFT, Quebral EPB, Ong EP, Catral CDM, Relador RJL, Velasco AJD, et al. Current status of diabetes mellitus care and management in the Philippines. Diabetes Metab Syndr 2024; 18(2): 102951. https://doi.org/10.1016/j.dsx.2024.102951
23. Xu S, Ming J, Jia A, Yu X, Cai J, Jing C, et al. Normal weight obesity and the risk of diabetes in Chinese people: a 9-year population-based cohort study. Sci Rep 2021; 11(1): 6090.
https://doi.org/10.1038/s41598-021-85573-z
24. Lynch JL, Barrientos-Pérez M, Hafez M, Jalaludin MY, Kovarenko M, Rao PV, et al. Country-Specific Prevalence and Incidence of Youth-Onset Type 2 Diabetes: A Narrative Literature Review. Ann Nutr Metab 2020; 76(5): 289-296.
https://doi.org/10.1159/000510499
25. Kivelä J, Wikström K, Virtanen E, Georgoulis M, Cardon G, Civeira F, et al; Feel4Diabetes research group. Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes - a narrative literature review. BMC Endocr Disord 2020; 20(Suppl 1): 140.
https://doi.org/10.1186/s12902-019-0468-y
26. Yaghootkar H, Whitcher B, Bell JD, Thomas EL. Ethnic differences in adiposity and diabetes risk - insights from genetic studies. J Intern Med 2020; 288(3): 271-283.
https://doi.org/10.1111/joim.13082
27. Atre S, Deshmukh S, Kulkarni M. Prevalence of type 2 diabetes mellitus (T2DM) in India: A systematic review (1994-2018). Diabetes Metab Syndr 2020; 14(5): 897-906.
https://doi.org/10.1016/j.dsx.2020.05.040
28. Andari E, Atallah P, Azar S, Echtay A, Jambart S, Saab C, et al. Experts' opinion on the detection and management of prediabetes in Lebanon. Sci Prog 2021; 104(3): 368504211029439.
https://doi.org/10.1177/00368504211029439
29. Luk AO. Changing landscape of diabetes in Asia - What are the unmet needs? J Diabetes Investig 2024; 15(4): 402-409.
https://doi.org/10.1111/jdi.14150
30. Siegel KR, Ali MK, Zhou X, Ng BP, Jawanda S, Proia K, et al. Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? Diabetes Care 2020; 43(7): 1557-1592. https://doi.org/10.2337/dci20-0017
31. Srinivasan S, Liju S, Sathish N, Siddiqui MK, Anjana RM, Pearson ER, et al. Common and Distinct Genetic Architecture of Age at Diagnosis of Diabetes in South Indian and European Populations. Diabetes Care 2023; 46(8): 1515-1523.
https://doi.org/10.2337/dc23-0243
32. Han C, Song Q, Ren Y, Chen X, Jiang X, Hu D. Global prevalence of prediabetes in children and adolescents: A systematic review and meta-analysis.J Diabetes 2022; 14(7): 434-441.
https://doi.org/10.1111/1753-0407.13291
33. Rao G, Jensen ET. Type 2 Diabetes in Youth. Glob Pediatr Health 2021; 7: 2333794X20981343.
https://doi.org/10.1177/2333794X20981343
34. Aggarwal R, Bibbins-Domingo K, Yeh RW, Song Y, Chiu N, Wadhera RK, et al. Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds. Ann Intern Med 2022; 175(6): 765-773.
https://doi.org/10.7326/M20-8079
35. Wallace AS, Wang D, Shin JI, Selvin E. Screening and Diagnosis of Prediabetes and Diabetes in US Children and Adolescents. Pediatrics 2020; 146(3): e20200265.
https://doi.org/10.1542/peds.2020-0265
36. Siddiqui MK, Anjana RM, Dawed AY, Martoeau C, Srinivasan S, Saravanan J, et al. Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function. Diabetologia 2022; 65(6): 973-983. Erratum in: Diabetologia 2022; 65(7): 1237.
https://doi.org/10.1007/s00125-022-05707-4
37. US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 326(8): 736-743.
https://doi.org/10.1001/jama.2021.12531
38. Caleyachetty R, Barber TM, Mohammed NI, Cappuccio FP, Hardy R, Mathur R, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol 2021; 9(7): 419-426. Erratum in: Lancet Diabetes Endocrinol 2021; 9(7): e2.
https://doi.org/10.1016/S2213-8587(21)00151-0
39. Wright AK, Welsh P, Gill JMR, Kontopantelis E, Emsley R, Buchan I, et al. Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia 2020; 63(8): 1542-1553.
https://doi.org/10.1007/s00125-020-05169-6
40. Jonas DE, Crotty K, Yun JD, Middleton JC, Feltner C, Taylor-Phillips S, et al. Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021; 326(8): 744-760.
41. Gujral UP, Kanaya AM. Epidemiology of diabetes among South Asians in the United States: lessons from the MASALA study. Ann New York Acad Sci 2021; 1495(1): 24-39.
https://doi.org/10.1111/nyas.14530
42. Shariff AI, Kumar N, Yancy WS, Corsino L. Type 2 diabetes and atherosclerotic cardiovascular disease in South Asians: a unique population with a growing challenge. Cur Diabetes Rep 2020; 20: 1-8. https://doi.org/10.1007/s11892-020-1291-6
43. Fang M, Wang D, Coresh J, Selvin E. Undiagnosed diabetes in US adults: prevalence and trends. Diabetes Care 2022; 45(9): 1994-2002.
https://doi.org/10.2337/dc22-0242
44. Gujral UP, Jagannathan R, He S, Huang M, Staimez LR, Wei J, et al. Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis. BMJ Open Diabetes Res Care 2021; 9(1): e001776.
https://doi.org/10.1136/bmjdrc-2020-001776
45. Haw JS, Shah M, Turbow S, Egeolu M, Umpierrez G. Diabetes complications in racial and ethnic minority populations in the USA. Curr Diab Rep 2021; 21(1): 2.
https://doi.org/10.1007/s11892-020-01369-x
46. Ranasinghe P, Jayawardena R, Gamage N, Sivanandam N, Misra A. Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults. Ann Epidemiol 2021; 58: 128-148.
https://doi.org/10.1016/j.annepidem.2021.02.016
47. Xie J, Wang M, Long Z, Ning H, Li J, Cao Y, et al. Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019. BMJ 2022; 379: e072385.
https://doi.org/10.1136/bmj-2022-072385
48. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in. Diabetes Care 2023; 46(Supplement_1):S19–S40. https://doi.org/10.2337/dc23-S002
Downloads
Published
License
Copyright (c) 2025 Sikandar Hayat Khan, Muhammad Qaiser Alam Khan, Asma Hayat, Usman Munir, Muhammad Anwar, Asif Ali, Eijaz Ghani

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





